<\/p>\n
Setrol-injectie<\/strong> bevat sodium tetradecyl sulfate (STS) 3% or 1%<\/strong> \u2014 a detergent sclerosing agent used by trained clinicians for sclerotherapy of varicose veins and telangiectasias (spider veins). It is delivered as a foamed or liquid intravenous injection into the affected vein under ultrasound or visual guidance. This is NOT a self-administered medication.<\/strong><\/p>\n<\/div>\n \ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n Sodium tetradecyl sulfate (STS, also known as STD or sotradecol) is a long-chain fatty-alcohol sulphate detergent. When injected into a vein, it disrupts the endothelial cell membrane, causing an inflammatory cascade that leads to thrombosis, fibrosis and eventually fibrotic obliteration of the vein lumen. The vein is then absorbed and disappears over weeks to months. STS is one of two FDA-approved sclerosants in the United States (the other is polidocanol).<\/p>\n Setrol Injection must be administered by a vascular surgeon, dermatologist, interventional radiologist or other physician trained in sclerotherapy. Inadvertent intra-arterial injection causes ischaemic limb necrosis. Extravasation causes skin sloughing. Foam STS injection above the level of the heart is associated with rare visual disturbance and migraine-like aura. Self-administration is not safe.<\/p>\n<\/div>\nWhat sodium tetradecyl sulfate is<\/h2>\n
Sclerotherapy is a procedure \u2014 not a self-injection medication<\/h3>\n
Indicaties<\/h2>\n
\n
Concentrations and use<\/h2>\n